Find clinical trials for Bristol Myers Squibb. Search for Bristol Myers Squibb clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 83
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for
Alzheimer's Disease
Location: Halifax, East Providence RI, Newton MA, Quebec,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976216
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Effect of KarXT on Urological Safety
for
Schizophrenia
Location: Marlton NJ, Philadelphia PA, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07221877
Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
for
Bipolar Disorder Type I With Mania
Location: New Haven CT, Staten Island NY, Marlton NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06929273
Phase3, Recruiting
Active & Responsive
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for
Alzheimer Disease
Location: North Dartmouth MA, Boston MA, Belmont MA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT06585787
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
for
Mania, Bipolar Disorder
Location: Staten Island NY, Hallandale FL, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07140913
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Location: New Haven CT, Staten Island NY, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951698
Phase3, Recruiting
Active & Responsive
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
for
Anemia, Sickle Cell, Healthy Volunteers
Location: Boston MA, New Haven CT, Philadelphia PA, Richmond VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06481306
Phase1, Phase2, Recruiting
Active & ResponsiveNew
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
for
Arthritis, Rheumatoid
Location: Denver CO
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07412704
Phase1, Phase2, Recruiting
Active & Responsive
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Locally Advanced Non-Small Cell Lung Cancer (NSCLC),
Location: Omaha NE, Grand Island NE
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680764
Phase2, Recruiting
Active & Responsive
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)